| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Good Drug Made Better: The Fulvestrant Dose-Response Story
|
Robertson, John F.R.
|
|
2014
|
14 |
6 |
p. 381-389
9 p.
|
artikel
|
| 2 |
Analysis of MET Genetic Aberrations in Patients With Breast Cancer at MD Anderson Phase I Unit
|
de Melo Gagliato, Debora
|
|
2014
|
14 |
6 |
p. 468-474
7 p.
|
artikel
|
| 3 |
A Novel Approach of INTRABEAM Intraoperative Radiotherapy for Nipple-Sparing Mastectomy With Breast Reconstruction
|
Pan, Lingxiao
|
|
2014
|
14 |
6 |
p. 435-441
7 p.
|
artikel
|
| 4 |
Associations of Hormone-Related Factors With Breast Cancer Risk According to Hormone Receptor Status Among White and African American Women
|
Cui, Yong
|
|
2014
|
14 |
6 |
p. 417-425
9 p.
|
artikel
|
| 5 |
Breast Cancer in Adolescent and Young Adult Women
|
Gewefel, Hanan
|
|
2014
|
14 |
6 |
p. 390-395
6 p.
|
artikel
|
| 6 |
Detection of Circulating Cytokeratin-19 mRNA-Positive Cells in the Blood and the Mitotic Index of the Primary Tumor Have Independent Prognostic Value in Early Breast Cancer
|
Tryfonidis, Konstantinos
|
|
2014
|
14 |
6 |
p. 442-450
9 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2014
|
14 |
6 |
p. A2-
1 p.
|
artikel
|
| 8 |
Endocrine Therapy for Breast Cancer: Assessing an Array of Women's Treatment Experiences and Perceptions, Their Perceived Self-Efficacy and Nonadherence
|
Wouters, Hans
|
|
2014
|
14 |
6 |
p. 460-467.e2
46241 p.
|
artikel
|
| 9 |
Extended Therapy With Letrozole and Ovarian Suppression in Premenopausal Patients With Breast Cancer After Tamoxifen
|
Ruddy, Kathryn J.
|
|
2014
|
14 |
6 |
p. 413-416
4 p.
|
artikel
|
| 10 |
Impact of Tumor Removal on the Systemic Oxidative Profile of Patients With Breast Cancer Discloses Lipid Peroxidation at Diagnosis as a Putative Marker of Disease Recurrence
|
Herrera, Ana Cristina S.
|
|
2014
|
14 |
6 |
p. 451-459
9 p.
|
artikel
|
| 11 |
Improving Breast Cancer Therapy With CDK4/6 Inhibitors
|
Jaganathan, Hamsa
|
|
2014
|
14 |
6 |
p. 379-380
2 p.
|
artikel
|
| 12 |
Phase 2, Multicenter, Single-Arm Study of Eribulin Mesylate With Trastuzumab as First-Line Therapy for Locally Recurrent or Metastatic HER2-Positive Breast Cancer
|
Wilks, Sharon
|
|
2014
|
14 |
6 |
p. 405-412
8 p.
|
artikel
|
| 13 |
Reproductive Factors and Subtypes of Breast Cancer Defined by Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2: A Register-Based Study From Korea
|
Lee, Jung Sun
|
|
2014
|
14 |
6 |
p. 426-434
9 p.
|
artikel
|
| 14 |
Table of Contents
|
|
|
2014
|
14 |
6 |
p. A5-A7
nvt p.
|
artikel
|
| 15 |
Trabectedin as a Single-Agent Treatment of Advanced Breast Cancer After Anthracycline and Taxane Treatment: A Multicenter, Randomized, Phase II Study Comparing 2 Administration Regimens
|
Goldstein, Lori J.
|
|
2014
|
14 |
6 |
p. 396-404
9 p.
|
artikel
|
| 16 |
Utilizing Microtubule Dynamics Inhibitor Therapeutics in the Management of Patients With Metastatic Breast Cancer
|
Seidman, Andrew D.
|
|
2014
|
14 |
6 |
p. e111-
1 p.
|
artikel
|
Tijdschrift beschrijving